Marshall Wace LLP Acquires Shares of 88,780 Myomo, Inc. (NYSEAMERICAN:MYO)

Marshall Wace LLP acquired a new stake in Myomo, Inc. (NYSEAMERICAN:MYO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 88,780 shares of the company's stock, valued at approximately $572,000. Marshall Wace LLP owned 0.29% of Myomo as of its most recent SEC filing.

Several other large investors have also bought and sold shares of MYO. Jump Financial LLC acquired a new stake in shares of Myomo in the fourth quarter worth $228,000. Portolan Capital Management LLC acquired a new stake in Myomo during the 4th quarter worth about $2,446,000. Walleye Capital LLC purchased a new position in Myomo during the 4th quarter valued at about $66,000. Renaissance Technologies LLC increased its holdings in shares of Myomo by 39.5% in the 4th quarter. Renaissance Technologies LLC now owns 199,600 shares of the company's stock valued at $1,285,000 after purchasing an additional 56,500 shares during the period. Finally, Aristides Capital LLC acquired a new stake in shares of Myomo during the fourth quarter worth approximately $1,288,000. Institutional investors own 44.99% of the company's stock.

Analyst Ratings Changes

MYO has been the topic of a number of recent analyst reports. Alliance Global Partners reissued a "buy" rating on shares of Myomo in a research note on Tuesday, March 11th. HC Wainwright raised their price target on Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a research report on Wednesday, March 12th. Craig Hallum increased their target price on Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a research note on Tuesday, March 11th. Finally, Ascendiant Capital Markets boosted their target price on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a research report on Monday, March 17th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $9.75.

Insider Buying and Selling

In other Myomo news, insider Harry Kovelman sold 30,000 shares of the stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $5.50, for a total transaction of $165,000.00. Following the completion of the transaction, the insider now owns 97,973 shares in the company, valued at approximately $538,851.50. This represents a 23.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas F. Kirk acquired 7,400 shares of Myomo stock in a transaction dated Thursday, March 13th. The shares were purchased at an average cost of $5.00 per share, with a total value of $37,000.00. Following the completion of the transaction, the director now directly owns 255,933 shares of the company's stock, valued at $1,279,665. This trade represents a 2.98 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 4.54% of the stock is owned by insiders.

Myomo Stock Down 27.9 %

NYSEAMERICAN MYO traded down $1.35 during trading hours on Thursday, hitting $3.49. The company's stock had a trading volume of 951,104 shares, compared to its average volume of 349,634. The stock has a fifty day moving average of $4.85. Myomo, Inc. has a twelve month low of $2.76 and a twelve month high of $7.17. The firm has a market cap of $105.57 million, a price-to-earnings ratio of -15.17 and a beta of 1.68.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.